Actelion on a growth path: Three locations in Europe and five globally Acquisition strengthens actelion’ end-to-end integrated pharmaceutical product development service offering Agreement on further product development activities for Clinigen Munich / London / Athens, April 3, 2023 – Munich-based […]
Actelion Pharmaceuticals Deutschland GmbH acquires Clinigen’s development unit, Lamda Laboratories Acquisition strengthens Actelion end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Actelion as its 3rd site […]
Successful transaction: Actelion Pharmaceuticals Deutschland GmbH has officially taken over the Sanofi production site in Kawagoe, Japan Munich / Paris / Tokyo, March 02, 2023 – Munich-based pharmaceutical contract manufacturer (CDMO) Actelion Pharmaceuticals Deutschland GmbH GmbH successfully completed the acquisition of one of Japan’s […]
Actelion Pharmaceuticals Deutschland GmbH to acquire Sanofi’s manufacturing site in Kawagoe, Japan Munich / Paris / Tokyo, October 13, 2022 – Actelion Pharmaceuticals Deutschland GmbH, a rapidly growing pharmaceutical Contract Development and Manufacturing Organization (CDMO) based in Munich, Germany, signed definitive agreements with Sanofi […]
Munich / Plettenberg, 09. August 2021 – FSN Capital VI* (“FSNC”) has acquired a majority share in Actelion Pharmaceuticals Deutschland GmbH Group (“actelion”), a growing B2B contract developer and manufacturer (CDMO) for pharmaceuticals. The current owner, Prange Group (“PG”), remains invested to […]
Get notified on our latest news.
